Nevi and melanoma in the pregnant woman

Clinics in Dermatology

Volumn 27, Issue 1, 2009, Pages 116-121

  Driscoll, Marcia S ^a   Grant Kels, Jane M ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; DACARBAZINE; ORAL CONTRACEPTIVE AGENT; TECHNETIUM 99M;

ARTICLE; DYSPLASTIC NEVUS; EPILUMINESCENCE MICROSCOPY; HORMONE SUBSTITUTION; HUMAN; MELANOCYTIC NEVUS; MELANOMA; NONHUMAN; PATIENT COUNSELING; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

FEMALE; HUMANS; MELANOMA; NEVUS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; SKIN NEOPLASMS;

EID: 57649104679     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2008.09.009     Document Type: Article

References (53)

1. Winton G.B., and Lewis C.W. Dermatoses of pregnancy. J Am Acad Dermatol 6 (1982) 977-998
2. Parmley T., and O'Brien T.J. Skin changes during pregnancy. Clin Obstet Gynecol 33 (1990) 713-717
3. Hu W., Nelson J.E., Mohney C.A., et al. Malignant melanoma arising in a pregnant African American woman with a congenital blue nevus. Dermatol Surg 30 (2004) 1530-1532
4. Foucar E., Bentley T.J., Laube D., et al. A histopathologic evaluation of nevocellular nevi in pregnancy. Arch Dermatol 121 (1985) 350-354
5. Sanchez J.L., Figueroa L.D., and Rodriguez E. Behavior of melanocytic nevi during pregnancy. Am J Dermatopathol 6 Suppl 1 (1984) 89-91
6. Ellis D.L. Pregnancy and sex steroid hormone effects on nevi of patients with the dysplastic nevus syndrome. J Am Acad Dermatol 25 (1991) 467-482
7. Pennoyer J.W., Grin C.M., Driscoll M.S., et al. Changes in size of melanocytic nevi during pregnancy. J Am Acad Dermatol 36 3 Pt 1 (1997) 378-382
8. Zampino M.R., Corazza M., Costantino D., Mollica G., and Virgili A. Are melanocytic nevi influenced by pregnancy? A dermatoscopic evaluation. Dermatol Surg 32 (2006) 1497-1504
9. Aktürk A.S., Bilen N., Bayrämgürler D., et al. Dermoscopy is a suitable method for the observation of the pregnancy-related changes in melanocytic nevi. J Eur Acad Dermatol Venereol 21 (2007) 1086-1090
10. Wyon Y., Synnerstad I., Fredrikson M., et al. Spectrophotometric analysis of melanocytic naevi during pregnancy. Acta Derm Venereol 87 (2007) 231-237
11. Stolz W., Riemann A., and Cognetta A.B. ABCD rule of dermoscopy: a new practical method of early recognition of malignant melanoma. Eur J Dermatol 4 (1994) 521-527
12. Moncrieff M., Cotton S., Claridge E., et al. Spectrophotometric intracutaneous analysis: a new technique for imaging pigmented skin lesions. Br J Dermatol 146 (2002) 448-457
13. Haniffa M.A., Lloyd J.J., and Lawrence C.M. The use of a spectrophotometric intracutaneous analysis device in the real-time diagnosis of melanoma in the setting of a melanoma screening clinic. Br J Dermatol 156 (2007) 1350-1352
14. Wang S.Q., Rabinovitz H., Kopf A.W., et al. Current techniques for the in vivo diagnosis of cutaneous melanoma. Clin Dermatol 22 (2004) 217-222
15. Pack G.T., and Scharnagel I.M. The prognosis for malignant melanoma in the pregnant woman. Cancer 4 (1951) 324-334
16. Byrd B.F., and McGanity W.J. The effect of pregnancy on the clinical course of malignant melanoma. South Med J 47 (1954) 196-200
17. Conybeare R.C. Malignant melanoma in pregnancy. Report of three cases. Obstet Gynecol 24 (1964) 451-454
18. Riberti C., Margola G., and Bertani A. Malignant melanoma: the adverse effect of pregnancy. Br J Plastic Surg 34 (1981) 338-339
19. Pennington D.G. Multiple primary melanoma in pregnancy: a case report. Br J Plastic Surg 36 (1983) 260-261
20. Driscoll M.S., Grin-Jorgensen C.M., and Grant-Kels J.M. Does pregnancy influence the prognosis of malignant melanoma?. J Am Acad Dermatol 29 (1993) 619-630
21. Reintgen D.S., McCarty K.S., Vollmer R., et al. Malignant melanoma and pregnancy. Cancer 55 (1985) 1340-1344
22. McManamny D.S., Moss A.L.H., Pocock P.V., et al. Melanoma and pregnancy: a long-term follow-up. Br J Obstet Gynecol 96 (1989) 1419-1423
23. Wong J.H., Sterns E.E., Kopald K.H., et al. Prognostic significance of pregnancy in stage I melanoma. Arch Surg 124 (1989) 1227-1231
24. Slinguff Jr. C.L., Reintgen D.S., Vollmer R., et al. Malignant melanoma arising during pregnancy: a study of 100 patients. Ann Surg 211 (1990) 552-559
25. Daryanani D., Plukker J.T., De Hullu J.A., et al. Pregnancy and early-stage melanoma. Cancer 97 (2003) 2248-2253
26. MacKie R.M., Bufalino R., Morabito A., et al. Lack of effect of pregnancy on outcome of melanoma. Lancet 337 (1991) 653-655
27. Driscoll M.S., and Grant-Kels J.M. Hormones, nevi, and melanoma: an approach to the patient. J Am Acad Dermatol 57 6 (2007) 919-931
28. Lens M.B., Rosdahl I., Ahlbom A., et al. Effect of pregnancy on survival in women with cutaneous malignant melanoma. J Clin Oncol 22 (2004) 4369-4375
29. O'Meara A.T., Cress R., Xing G., et al. Malignant melanoma in pregnancy: a population-based evaluation. Cancer 103 (2005) 1217-1226
30. Lawrence C. Drug management in skin surgery. Drugs 52 (1996) 805-817
31. Gormley D.E. Cutaneous surgery and the pregnant patient. J Am Acad Dermatol 23 (1990) 269-279
32. Rosenberg P.H., Veering B.T., and Urmey W.F. Maximum recommended doses of local anesthetics: a multifactorial concept. Reg Anesth Pain Med 29 (2004) 564-575
33. Squatrito R.C., and Harlow S.P. Melanoma complicating pregnancy. Obstet Gynecol Clin North Am 25 (1998) 407-416
34. Mondi M.M., Cuenca R.E., Ollila D.W., et al. Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol 14 1 (2007) 218-221
35. Keleher A., Wendt R., Delpassand E., Stachowiak A.M., and Kuerer H.M. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J 10 (2004) 492-495
36. Schwartz J.L., Mozurkewich E.L., and Johnson T.M. Current management of patients with melanoma who are pregnant, want to get pregnant, or do not want to get pregnant. Cancer 97 (2003) 2130-2133
37. Amersi F., and Hansen N.M. The benefits and limitations of sentinel lymph node biopsy. Curr Treat Options Oncol 7 (2006) 141-151
38. Shapiro R.L. Surgical approaches to malignant melanoma: practical guidelines. Dermatol Clin 20 (2002) 681-699
39. Campbell F.A., and Campbell C. Magnetic resonance imaging for stage IV melanoma during pregnancy. Arch Dermatol 142 (2006) 393
40. Egberts F., Lischner S., Russo P., et al. Diagnostic and therapeutic procedures for management of melanoma during pregnancy: risk for the fetus?. J Dtsch Dermatol Ges 4 (2006) 717-720
41. Beyeler M., Hafner J., Beinder E., et al. Special considerations for stage IV melanoma during pregnancy. Arch Dermatol 141 (2005) 1077-1078
42. Harkin K.P., Drumm J.E., O'Brien P., et al. Metastatic malignant melanoma in pregnancy. Ir Med J 83 (1990) 116-117
43. Karagas M.R., Stukel T.A., Dykes J., et al. A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use. Br J Cancer 86 (2002) 1085-1092
44. Gefeller O., Hassan K., and Wille L. Cutaneous malignant melanoma in women and the role of oral contraceptives. Br J Dermatol 138 (1998) 122-124
45. Palmer J.R., Rosenberg L., Strom B.L., et al. Oral contraceptive use and the risk of cutaneous malignant melanoma. Cancer Causes Control 3 (1992) 547-554
46. Holly E.A., Weiss N.S., and Liff J.M. Cutaneous melanoma in relation to exogenous hormones and reproductive factors. J Natl Cancer Inst 70 (1983) 827-831
47. Beral V., Evans S., Shaw H., et al. Oral contraceptive use and malignant melanoma in Australia. Br J Cancer 50 (1984) 681-685
48. Osterlind A., Tucker M.A., Stone B.J., et al. The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women. Int J Cancer 42 (1988) 821-824
49. Gallagher R.P., Elwood J.M., Hill G.B., et al. Reproductive factors, oral contraceptives, and risk of malignant melanoma: Western Canada melanoma study. Br J Cancer 52 (1985) 901-907
50. Holman C.D.J., Armstrong B.K., and Heenan P.J. Cutaneous malignant melanoma in females: exogenous sex hormones and reproductive factors. Br J Cancer 50 (1984) 673-680
51. Naldi L., Altieri A., Imberti G.L., et al. Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy. Ann Epidemiol 15 (2005) 545-550
52. Beral V., Ramcharan S., and Faris R. Malignant melanoma and oral contraceptive use among women in California. Br J Cancer 36 (1977) 804-809
53. Persson I., Yuen J., Berkvist L., et al. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy: long-term follow-up of a Swedish cohort. Int J Cancer 67 (1996) 327-332